Inhibition of this miR in mice implanted with AML CD34+ hematopoietic progenitor cells (HSPCs) increased myeloid differentiation, inhibited engraftment and infiltration of leukemic CD34+ cells into the bone marrow and spleen, and finally reduced leukemic symptoms [93]. This evidence concerns the gene CD34 and acute myeloid leukemia.